C Path Rare Orphan Disease Conference Day Three Am Sessions Sept 13 2023 Critical Path Institute Mp3 & Mp4 Download

3:00:25

c-path rare and orphan disease conference day 2 closing remarks - alexandre betourne

57:06

the role of integrated datasets in addressing rare diseases research challenges

57:07

investors perspective on opportunities in healthcare

58:21

shared stewardship in collaborative curation of rare disease datasets

3:25

vp of c-path rare and orphan disease programs collin hovinga talks rare disease drug development

36:48

c-path's rare & orphan disease conference - ontology applications in rare disease

1:44

c path rare and orphan conference closing remarks klaus romero

4:18

c-path's impact on rare disease drug development - klaus romero, ceo

11:08

rare disease endpoint advancement rdea pilot program

42:52

coa for rare diseases resource roll out

2:00

als advocate cathy collet discusses c-path's work in rare disease

51:54

impact of rare disease initiatives at ema and health canada

37:01

global rare disease initiative panel

1:24:07

regulatory pathway and applications in drug development for rare diseases

46:37

c-path rare & orphan disease conference day three am sessions sept 13, 2023

Download video MP4

Download video MP3

Similar videos

c-path rare & orphan disease conference am sessions sept 11, 2023

c-path rare & orphan disease conference pm sessions sept 11 2023

c-path rare & orphan disease conference day two pm sessions sept 12, 2023

c-path rare and orphan disease conference day two am sessions

c-path rare and orphan disease conference day 2 closing remarks - alexandre betourne

the role of integrated datasets in addressing rare diseases research challenges

investors perspective on opportunities in healthcare

shared stewardship in collaborative curation of rare disease datasets

vp of c-path rare and orphan disease programs collin hovinga talks rare disease drug development

c-path's rare & orphan disease conference - ontology applications in rare disease

c path rare and orphan conference closing remarks klaus romero

c-path's impact on rare disease drug development - klaus romero, ceo

rare disease endpoint advancement rdea pilot program

coa for rare diseases resource roll out

als advocate cathy collet discusses c-path's work in rare disease

impact of rare disease initiatives at ema and health canada

global rare disease initiative panel

regulatory pathway and applications in drug development for rare diseases

clinical trial simulation tools advancing treatments in rare disease